Dissecting the role of the foxp3 gene in the joint genetic susceptibility to autoimmune thyroiditis and diabetes: A genetic and functional analysis

Gene

Volumn 556, Issue 2, 2015, Pages 142-148

  Li, Cheuk Wun ^a   Concepcion, Erlinda ^a   Tomer, Yaron ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autoimmune thyroiditis; FOXP3; Gene splicing; Transcription; Type 1 diabetes

Indexed keywords

GENOMIC DNA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; ISOPROTEIN; MICROSATELLITE DNA;

ARTICLE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CONTROLLED STUDY; EXON; FOXP3 GENE; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEMIZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; LYMPH NODE; MICROSATELLITE MARKER; REGULATORY T LYMPHOCYTE; RNA SPLICING; THYMUS; X CHROMOSOME; ALTERNATIVE RNA SPLICING; GENETIC PREDISPOSITION; GENETICS; HEK293 CELL LINE; MALE; METABOLISM;

ALTERNATIVE SPLICING; CHROMOSOMES, HUMAN, X; DIABETES MELLITUS, TYPE 1; EXONS; FORKHEAD TRANSCRIPTION FACTORS; GENETIC PREDISPOSITION TO DISEASE; HEK293 CELLS; HUMANS; LYMPH NODES; MALE; MICROSATELLITE REPEATS; PROTEIN ISOFORMS; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 84919835108     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.11.064     Document Type: Article

References (78)

1. + Tregs. J. Clin. Invest. 2005, 115:3276-3284.
2. Anaya J.M., Castiblanco J., Tobon G.J., Garcia J., Abad V., Cuervo H., Velasquez A., Angel I.D., Vega P., Arango A. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J. Autoimmun. 2006, 26:208-214.
3. Ban Y., Tozaki T., Tobe T., Ban Y., Jacobson E.M., Concepcion E.S., Tomer Y. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J. Autoimmun. 2007, 28:201-207.
4. Bassuny W.M., Ihara K., Sasaki Y., Kuromaru R., Kohno H., Matsuura N., Hara T. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 2003, 55:149-156.
5. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelly T.E., Saulsbury F.T., Chance P.F., Ochs H.D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001, 27:20-21.
6. Betterle C., Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed. 2003, 74:9-33.
7. Betterle C., Zanette F., Pedini B., Presotto F., Rapp L.B., Monciotti C.M., Rigon F. Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 1984, 26:431-436.
8. Birlea S.A., Jin Y., Bennett D.C., Herbstman D.M., Wallace M.R., McCormack W.T., Kemp E.H., Gawkrodger D.J., Weetman A.P., Picardo M., Leone G., Taieb A., Jouary T., Ezzedine K., van Geel N., Lambert J., Overbeck A., Fain P.R., Spritz R.A. Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J. Investig. Dermatol. 2011, 131:371-381.
9. Bright G.M., Blizzard R.M., Kaiser D.L., Clarke W.L. Organ-specific autoantibodies in children with common endocrine diseases. J. Pediatr. 1982, 100:8-14.
10. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27:68-73.
11. Burek C.L., Rose N.R., Guire K.E., Hoffman W.H. Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity 1990, 7:157-167.
12. Camperio C., Caristi S., Fanelli G., Soligo M., Del Porto P., Piccolella E. Forkhead transcription factor FOXP3 upregulates CD25 expression through cooperation with RelA/NF-κB. PLoS One 2012, 7:e48303.
13. Chae W.J., Henegariu O., Lee S.K., Bothwell A.L. The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:9631-9636.
14. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., Bowcock A.M. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 2000, 106:R75-R81.
15. Cloutier J.F., Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med. 1999, 189:111-121.
16. Cooper T.A. Use of minigene systems to dissect alternative splicing elements. Methods 2005, 37:331-340.
17. Dabelea D., Mayer-Davis E.J., Saydah S., Imperatore G., Linder B., Divers J., Bell R., Badaru A., Talton J.W., Crume T., Liese A.D., Merchant A.T., Lawrence J.M., Reynolds K., Dolan L., Liu L.L., Hamman R.F., Study, S.f.D.i.Y. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014, 311:1778-1786.
18. D'Amico F., Skarmoutsou E., Marchini M., Malaponte G., Caronni M., Scorza R., Mazzarino M.C. Genetic polymorphisms of FOXP3 in Italian patients with systemic sclerosis. Immunol. Lett. 2013, 152:109-113.
19. Darendeliler F.F., Kadioglu A., Bas F., Bundak R., Gunoz H., Saka N., Neyzi O.R. Thyroid ultrasound in IDDM. J. Pediatr. Endocrinol. 1994, 7:33-37.
20. Dorman J., Kramer M.K., O'Lear L.A., Burke J.P., McCanlies E., McCarthy B.J., Trucco M., Swan J.S., Steenkiste A.R., Koehler A.N., Foley T.P. Molecular epidemiology of autoimmune thyroid disease. Gac. Med. Mex. 1997, 133(Suppl. 1):97-103.
21. Du J., Huang C., Zhou B., Ziegler S.F. Isoform-specific inhibition of ROR α-mediated transcriptional activation by human FOXP3. J. Immunol. 2008, 180:4785-4792.
22. Eisenbarth G.S., Gottlieb P.A. Autoimmune polyendocrine syndromes. N. Engl. J. Med. 2004, 350:2068-2079.
23. + regulatory T cells. Nat. Immunol. 2003, 4:330-336.
24. + exchanger intron 2 activates splicing. Eur. J. Biochem. 2001, 268:1076-1083.
25. Gao L., Li K., Li F., Li H., Liu L., Wang L., Zhang Z., Gao T., Liu Y. Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J. Dermatol. Sci. 2010, 57:51-56.
26. Golden B., Levin L., Ban Y., Concepcion E., Greenberg D.A., Tomer Y. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J. Clin. Endocrinol. Metab. 2005, 90:4904-4911.
27. Hasham A., Tomer Y. The recent rise in the frequency of type 1 diabetes: who pulled the trigger?. J. Autoimmun. 2011, 37:1-2.
28. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
29. Howson J.M., Dunger D.B., Nutland S., Stevens H., Wicker L.S., Todd J.A. A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 2007, 50:741-746.
30. Huber A., Menconi F., Corathers S., Jacobson E.M., Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr. Rev. 2008, 29:697-725.
31. Ichiyama K., Yoshida H., Wakabayashi Y., Chinen T., Saeki K., Nakaya M., Takaesu G., Hori S., Yoshimura A., Kobayashi T. Foxp3 inhibits RORγt-mediated IL-17A mRNA transcription through direct interaction with RORgt. J. Biol. Chem. 2008, 283:17003-17008.
32. Ikegami H., Awata T., Kawasaki E., Kobayashi T., Maruyama T., Nakanishi K., Shimada A., Amemiya S., Kawabata Y., Kurihara S., Tanaka S., Kanazawa Y., Mochizuki M., Ogihara T. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J. Clin. Endocrinol. Metab. 2006, 91:1087-1092.
33. Inoue N., Watanabe M., Morita M., Tomizawa R., Akamizu T., Tatsumi K., Hidaka Y., Iwatani Y. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin. Exp. Immunol. 2010, 162:402-406.
34. Jacobson E.M., Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J. Autoimmun. 2007, 28:85-98.
35. Jaeger C., Hatziagelaki E., Petzoldt R., Bretzel R.G. Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects. Diabetes Care 2001, 24:27-32.
36. Jenkins R.C., Weetman A.P. Disease associations with autoimmune thyroid disease. Thyroid 2002, 12:977-988.
37. Katoh H., Zheng P., Liu Y. FOXP3: genetic and epigenetic implications for autoimmunity. J. Autoimmun. 2013, 41:72-78.
38. Kaufmann E., Knochel W. Five years on the wings of fork head. Mech. Dev. 1996, 57:3-20.
39. Kaur G., Goodall J.C., Jarvis L.B., Hill Gaston J.S. Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells-identification of Foxp3δ7 in human regulatory T cells. Mol. Immunol. 2010, 48:321-332.
40. + T regulatory cells. Nat. Immunol. 2003, 4:337-342.
41. Kontiainen S., Schlenzka A., Koskimies S., Rilva A., Maenpaa J. Autoantibodies and autoimmune diseases in young diabetics. Diabetes Res. 1990, 13:151-156.
42. Krejsgaard T., Gjerdrum L.M., Ralfkiaer E., Lauenborg B., Eriksen K.W., Mathiesen A.M., Bovin L.F., Gniadecki R., Geisler C., Ryder L.P., Zhang Q., Wasik M.A., Odum N., Woetmann A. Malignant Tregs express low molecular splice forms of FOXP3 in Sezary syndrome. Leukemia 2008, 22:2230-2239.
43. Landschulz W.H., Johnson P.F., McKnight S.L. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 1988, 240:1759-1764.
44. Levin L., Ban Y., Concepcion E., Davies T.F., Greenberg D.A., Tomer Y. Analysis of HLA genes in families with autoimmune diabetes and thyroiditis. Hum. Immunol. 2004, 65:640-647.
45. Lin Y.C., Lee J.H., Wu A.S., Tsai C.Y., Yu H.H., Wang L.C., Yang Y.H., Chiang B.L. Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: a case-control study. Lupus 2011, 20:137-143.
46. Lindberg B., Ericsson U.B., Ljung R., Ivarsson S.A. High prevalence of thyroid autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children. J. Lab. Clin. Med. 1997, 130:585-589.
47. Lopes J.E., Torgerson T.R., Schubert L.A., Anover S.D., Ocheltree E.L., Ochs H.D., Ziegler S.F. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J. Immunol. 2006, 177:3133-3142.
48. Lorini R., d'Annunzio G., Vitali L., Scaramuzza A. IDDM and autoimmune thyroid disease in the pediatric age group. J. Pediatr. Endocrinol. Metab. 1996, 9(Suppl. 1):89-94.
49. Mailer R.K., Falk K., Rotzschke O. Absence of leucine zipper in the natural FOXP3δ2δ7 isoform does not affect dimerization but abrogates suppressive capacity. PLoS One 2009, 4:e6104.
50. Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2001, 2:816-822.
51. + tolerogenic endothelial cells, inhibiting alloreactivity. Int. Immunol. 2004, 16:1055-1068.
52. Marson A., Kretschmer K., Frampton G.M., Jacobsen E.S., Polansky J.K., MacIsaac K.D., Levine S.S., Fraenkel E., von Boehmer H., Young R.A. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007, 445:931-935.
53. McCanlies E., O'Leary L.A., Foley T.P., Kramer M.K., Burke J.P., Libman A., Swan J.S., Steenkiste A.R., McCarthy B.J., Trucco M., Dorman J.S. Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J. Clin. Endocrinol. Metab. 1998, 83:1548-1551.
54. McKenna M.J., Herskowitz R., Wolfsdorf J.I. Screening for thyroid disease in children with IDDM. Diabetes Care 1990, 13:801-803.
55. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., Miyachi Y., Tsukada T., Sakaguchi S. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007, 446:685-689.
56. Owen C.J., Eden J.A., Jennings C.E., Wilson V., Cheetham T.D., Pearce S.H. Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J. Mol. Endocrinol. 2006, 37:97-104.
57. Pagani F., Buratti E., Stuani C., Romano M., Zuccato E., Niksic M., Giglio L., Faraguna D., Baralle F.E. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J. Biol. Chem. 2000, 275:21041-21047.
58. Park O., Grishina I., Leung P.S., Gershwin M.E., Prindiville T. Analysis of the Foxp3/scurfin gene in Crohn's disease. Ann. N. Y. Acad. Sci. 2005, 1051:218-228.
59. Payami H., Joe S., Thomson G. Autoimmune thyroid disease in type I diabetic families. Genet. Epidemiol. 1989, 6:137-141.
60. Riley W.J., Maclaren N.K., Lezotte D.C., Spillar R.P., Rosenbloom A.L. Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J. Pediatr. 1981, 99:350-354.
61. Saccucci P., Del Duca E., Rapini N., Verrotti A., Piccinini S., Maccari A., Canu G., Angelini F., Fontana L., Giannini C., Chiarelli F., Manca Bitti M.L., Bottini N. Association between PTPN22 C1858T and type 1 diabetes: a replication in continental Italy. Tissue Antigens 2008, 71:234-237.
62. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 2001, 182:18-32.
63. Santamaria P., Barbosa J.J., Lindstrom A.L., Lemke T.A., Goetz F.C., Rich S.S. HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves' disease in type I diabetic patients. J. Clin. Endocrinol. Metab. 1994, 78:878-883.
64. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 2001, 276:37672-37679.
65. + T-cell activation. Immunology 2006, 119:203-211.
66. Sougioultzoglou F., Falorni A., Kassi G., Brozzetti A., Karamitsos D., Koliakos G.G. Coincidence of high antiislet and antithyroid autoantibody titles in first-degree relatives of patients with type 1 diabetes. Exp. Clin. Endocrinol. Diabetes 2005, 113:85-89.
67. Stefan M., Jacobson E.M., Huber A.K., Greenberg D.A., Li C.W., Skrabanek L., Conception E., Fadlalla M., Ho K., Tomer Y. Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. J. Biol. Chem. 2011, 286:31168-31179.
68. Stefan M., Zhang W., Concepcion E., Yi Z., Tomer Y. DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology. J. Autoimmun. 2014, 50:33-37.
69. Teft W.A., Kirchhof M.G., Madrenas J. A molecular perspective of CTLA-4 function. Annu. Rev. Immunol. 2006, 24:65-97.
70. Torfs C.P., King M.C., Huey B., Malmgren J., Grumet F.C. Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis. Am. J. Hum. Genet. 1986, 38:170-187.
71. Villano M.J., Huber A.K., Greenberg D.A., Golden B.K., Concepcion E., Tomer Y. Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J. Clin. Endocrinol. Metab. 2009, 94:1458-1466.
72. - T cells. J. Clin. Invest. 2003, 112:1437-1443.
73. Wildin R.S., Freitas A. IPEX and FOXP3: clinical and research perspectives. J. Autoimmun. 2005, 25:56-62. (Suppl.).
74. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., Levy-Lahad E., Mazzella M., Goulet O., Perroni L., Bricarelli F.D., Byrne G., McEuen M., Proll S., Appleby M., Brunkow M.E. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001, 27:18-20.
75. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., Bates D.L., Guo L., Han A., Ziegler S.F., Mathis D., Benoist C., Chen L., Rao A. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006, 126:375-387.
76. + regulatory T cells. Int. Immunol. 2004, 16:1643-1656.
77. Zavattari P., Deidda E., Pitzalis M., Zoa B., Moi L., Lampis R., Contu D., Motzo C., Frongia P., Angius E., Maioli M., Todd J.A., Cucca F. No association between variation of the FOXP3 gene and common type 1 diabetes in the Sardinian population. Diabetes 2004, 53:1911-1914.
78. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007, 445:936-940.